Preclinical efficacy of sepantronium bromide (YM155) in multiple myeloma is conferred by down regulation of Mcl-1 - Wagner, Verena; Hose, Dirk; Seckinger, Anja; Weiz, Ludmila; Meißner, Tobias; Breitkreutz, Iris; Podar, Klaus; Ho, Anthony Dick; Goldschmidt, Hartmut; Krämer, Alwin; Raab, Marc-Steffen (OncoTarget, 2014)
Gesehen am 28.07.2020